BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33220581)

  • 1. Metformin inhibits proliferation of oral squamous cell carcinoma cells by suppressing proteolysis of nerve growth factor receptor.
    Wei J; Huang J; Kuang Y; Li Y; Zhong D; Song J
    Arch Oral Biol; 2021 Jan; 121():104971. PubMed ID: 33220581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma.
    Chen C; Shin JH; Eggold JT; Chung MK; Zhang LH; Lee J; Sunwoo JB
    Oncotarget; 2016 Oct; 7(43):70738-70749. PubMed ID: 27683113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
    Liu J; Zhao J; Qiao X
    Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The inhibitory effect of metformin on oral squamous cell carcinoma].
    Wang L; Wang Z; Zhao X; Ji N; Zhou Y; Li J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jun; 50(6):360-5. PubMed ID: 26359040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
    Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
    Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
    Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator.
    Zhou X; Hao Q; Liao P; Luo S; Zhang M; Hu G; Liu H; Zhang Y; Cao B; Baddoo M; Flemington EK; Zeng SX; Lu H
    Elife; 2016 Jun; 5():. PubMed ID: 27282385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits oral squamous cell carcinoma progression through regulating RNA alternative splicing.
    Ji M; Lv Y; Chen C; Xing D; Zhou C; Zhao J; Qi Y; Zhang J; Wang Y; Ma X; Xu W; Zhang W; Li X
    Life Sci; 2023 Feb; 315():121274. PubMed ID: 36509195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
    Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
    Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
    Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
    Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma.
    Ren A; Qiu Y; Cui H; Fu G
    Oral Dis; 2015 Jul; 21(5):558-64. PubMed ID: 25581076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral Cancer.
    Doan C; Aouizerat BE; Ye Y; Dang D; Asam K; Bhattacharya A; Howard T; Patel YK; Viet DT; Figueroa JD; Zhong JF; Thomas CM; Morlandt AB; Yu G; Callahan NF; Allen CT; Grandhi A; Herford AS; Walker PC; Nguyen K; Kidd SC; Lee SC; Inman JC; Slater JM; Viet CT
    Adv Biol (Weinh); 2022 Sep; 6(9):e2200190. PubMed ID: 35925599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma.
    He Y; Tai S; Deng M; Fan Z; Ping F; He L; Zhang C; Huang Y; Cheng B; Xia J
    Cancer Med; 2019 Jul; 8(7):3479-3490. PubMed ID: 31025540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.